EXPRS2.ST

ExpreS2ion Biotech Holding AB (publ) [EXPRS2.ST] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

EXPRS2.ST Stock Summary

In the News

EXPRS2.ST Financial details

Company Rating
Neutral
Market Cap
168.35M
Income
-126.71M
Revenue
6.91M
Book val./share
1.62
Cash/share
1.57
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
-1.45
Forward P/E
-
PEG
-0.1
P/S
27.7
P/B
2.29
P/C
2.04
P/FCF
-1.5
Quick Ratio
4.04
Current Ratio
5
Debt / Equity
0.03
LT Debt / Equity
-
-
-
EPS (TTM)
-2.99
EPS next Y
-
EPS next Q
-
EPS this Y
139.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
21.11%
Revenue last 5Y
-10.52%
Revenue Q/Q
-24.31%
EPS Q/Q
-30.16%
-
-
-
-
SMA20
-
SMA50
-
SMA100
200%
Inst Own
-
Inst Trans
-
ROA
-124%
ROE
-139%
ROC
-1.67%
Gross Margin
36%
Oper. Margin
-2003%
Profit Margin
-1833%
Payout
-
Shs Outstand
51.41M
Shs Float
51.39M
-
-
-
-
Target Price
-
52W Range
0.713-10.871439
52W High
-
52W Low
-
RSI
50
Rel Volume
0.07
Avg Volume
1.63M
Volume
118.33K
Perf Week
-7.78%
Perf Month
-12.33%
Perf Quarter
125.35%
Perf Half Y
-0.93%
-
-
-
-
Beta
1.812
-
-
Volatility
0.11%, 0.13%
Prev Close
0%
Price
3.2
Change
5.61%

EXPRS2.ST Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.60.830.160.350.13
Net income per share
-1.14-1-0.96-1.24-2.97
Operating cash flow per share
-0.87-0.76-0.55-1.29-2.49
Free cash flow per share
-0.93-0.8-0.58-1.31-2.5
Cash per share
0.420.323.233.932.78
Book value per share
0.56-0.062.863.972.59
Tangible book value per share
-0.01-0.452.733.882.51
Share holders equity per share
0.56-0.062.863.972.59
Interest debt per share
0.10.150.180.050.07
Market cap
93.34M64.74M360.63M1.3B660.25M
Enterprise value
88.01M60.81M256.18M1.26B551.13M
P/E ratio
-5.55-3.88-11.37-29.6-5.57
Price to sales ratio
10.534.6868.57106.26129.82
POCF ratio
-7.25-5.1-19.84-28.48-6.63
PFCF ratio
-6.82-4.84-18.92-28.04-6.6
P/B Ratio
11.24-603.819.266.39
PTB ratio
11.24-603.819.266.39
EV to sales
9.924.448.71103.38108.36
Enterprise value over EBITDA
-5.63-3.99-9-27.67-4.43
EV to operating cash flow
-6.83-4.79-14.1-27.71-5.53
EV to free cash flow
-6.43-4.55-13.44-27.28-5.51
Earnings yield
-0.18-0.26-0.09-0.03-0.18
Free cash flow yield
-0.15-0.21-0.05-0.04-0.15
Debt to equity
0.11-1.380.030.010.02
Debt to assets
0.040.080.020.010.01
Net debt to EBITDA
0.340.263.670.770.88
Current ratio
2.150.836.1819.634.2
Interest coverage
-29.59-16.78-8.830-146.51
Income quality
0.710.70.580.940.78
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.810.624.080.290
Research and developement to revenue
0000.814.02
Intangibles to total assets
0.40.340.030.020.02
Capex to operating cash flow
0.060.050.050.020
Capex to revenue
-0.09-0.05-0.17-0.06-0.08
Capex to depreciation
-0.31-0.24-0.3-0.4-0.31
Stock based compensation to revenue
00000
Graham number
3.811.217.8510.5313.15
ROIC
-1.77-34.44-0.29-0.31-1.14
Return on tangible assets
-1.34-1.36-0.28-0.3-0.88
Graham Net
-0.43-0.862.493.61.93
Working capital
5.79M-2.08M94.25M139M100.52M
Tangible asset value
-112K-7.5M90.45M137.2M100.37M
Net current asset value
-1.82M-9.65M88.15M134.85M97.91M
Invested capital
0.11-1.380.030.010.02
Average receivables
00000
Average payables
538.5K844.5K1.58M1.88M6.92M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
80.48116.19124.381.86872.95
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
4.543.142.944.460.42
Inventory turnover
00000
ROE
-2.0315.48-0.34-0.31-1.15
Capex per share
-0.06-0.04-0.03-0.02-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.020.020.070.040.03
Net income per share
-0.76-1.22-0.7-0.63-0.44
Operating cash flow per share
-0.58-0.99-1.05-0.72-0.25
Free cash flow per share
-0.58-0.99-1.08-0.74-0.25
Cash per share
3.712.781.911.861.57
Book value per share
3.72.592.112.121.62
Tangible book value per share
3.622.512.112.121.62
Share holders equity per share
3.72.592.112.121.62
Interest debt per share
0.050.050.060.040.07
Market cap
384.68M660.25M199.13M181.14M69.02M
Enterprise value
236.93M551.13M129.16M94.95M-6.08M
P/E ratio
-3.13-3.4-1.89-1.51-0.79
Price to sales ratio
461.8679.2777.694.2947.47
POCF ratio
-16.48-16.74-5.04-5.31-5.62
PFCF ratio
-16.42-16.66-4.89-5.2-5.61
P/B Ratio
2.586.392.511.80.86
PTB ratio
2.586.392.511.80.86
EV to sales
284.4356750.3449.43-4.18
Enterprise value over EBITDA
-7.61-10.41-4.36-2.890.28
EV to operating cash flow
-10.15-13.98-3.27-2.780.5
EV to free cash flow
-10.11-13.91-3.17-2.720.49
Earnings yield
-0.08-0.07-0.13-0.17-0.32
Free cash flow yield
-0.06-0.06-0.2-0.19-0.18
Debt to equity
0.010.020.030.020.03
Debt to assets
0.010.010.020.020.02
Net debt to EBITDA
4.752.062.362.633.46
Current ratio
8.854.24.729.215
Interest coverage
-91-631.93-96.370-17.99
Income quality
0.710.741.321.030.55
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
23.839.115.619.186.86
Intangibles to total assets
0.020.020.030.020.03
Capex to operating cash flow
000.030.020
Capex to revenue
-0.11-0.2-0.48-0.39-0.02
Capex to depreciation
-0.280000
Stock based compensation to revenue
00000
Graham number
7.978.415.775.54.02
ROIC
-0.21-0.46-0.32-0.31-0.25
Return on tangible assets
-0.18-0.36-0.26-0.27-0.22
Graham Net
3.181.931.281.541.12
Working capital
146.45M100.52M76.11M96.94M76.29M
Tangible asset value
145.86M100.37M76.6M97.81M77.4M
Net current asset value
143.49M97.91M72.93M93.53M73.53M
Invested capital
0.010.020.030.020.03
Average receivables
00000
Average payables
9.39M12.57M11.98M7.07M2.78M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
706.93822.32791.05213.48367.51
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0.130.110.110.420.24
Inventory turnover
00000
ROE
-0.21-0.47-0.33-0.3-0.27
Capex per share
00-0.03-0.020

EXPRS2.ST Frequently Asked Questions

What is ExpreS2ion Biotech Holding AB (publ) stock symbol ?

ExpreS2ion Biotech Holding AB (publ) is a DK stock and trading under the symbol EXPRS2.ST

What is ExpreS2ion Biotech Holding AB (publ) stock quote today ?

ExpreS2ion Biotech Holding AB (publ) stock price is $3.2 today.

Is ExpreS2ion Biotech Holding AB (publ) stock public?

Yes, ExpreS2ion Biotech Holding AB (publ) is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Same Price Range
Similar Market Cap